Clinical Trials Directory

Trials / Unknown

UnknownNCT04986826

Exercise Effect on Transthyretin Stability

Exercise Effect on Transthyretin Stability in Master Athletes and Patients With Transthyretin Amyloidosis

Status
Unknown
Phase
Study type
Observational
Enrollment
24 (estimated)
Sponsor
Oregon Health and Science University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

The goal of this study to investigate if exercise predisposes to transthyretin instability. The investigators will evaluate the effect of exercise on transthyretin biochemistry.

Detailed description

This is an investigator initiated observational study, designed to study the effect of exercise on transthyretin stability in three main populations: Group 1: healthy master athletes who are 60 years or older. Group 2: Genotype positive (G+) cardiac phenotype negative (P-) patients with variant ATTR (i.e. carriers without evidence of disease). Group 3: Patients with ATTR CA who have not been on a stabilizer (tafamidis) within the last 14 days prior to enrollment.

Conditions

Timeline

Start date
2021-07-15
Primary completion
2021-11-30
Completion
2021-12-30
First posted
2021-08-03
Last updated
2021-08-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04986826. Inclusion in this directory is not an endorsement.

Exercise Effect on Transthyretin Stability (NCT04986826) · Clinical Trials Directory